Patients undergoing treatment for lymphoma often experience adverse side effects that can be so severe that they stop or slow treatment. But a new study shows that a virtual program focusing on diet and exercise is a feasible strategy for minimising the side effects of cancer therapies and increasing treatment retention.
Early findings from the LIFE-L study will be presented on behalf of the multidisciplinary team by Melissa Lopez, Ph.D., RDN, at the American Society of Haematology (ASH) annual meeting in Orlando. Lopez is a postdoctoral associate in the CRANE Lab at Sylvester Comprehensive Cancer Centre, part of the University of Miami Miller School of Medicine.